VCF1

VCF1 (FAM104A) is a nuclear cofactor of the AAA+ ATPase p97/VCP that controls the nuclear pool and activity of p97 in ubiquitin-dependent protein degradation (PMID:37713320). VCF1 binds the p97 N-domain directly through a conserved alpha-helical motif that recognizes p97 with unusually high affinity, exceeding that of other known p97 cofactors (PMID:38503733). Through this interaction VCF1 localizes to the nucleus and promotes nuclear import of p97, such that its loss reduces nuclear p97 levels (PMID:37713320). VCF1 forms joint complexes with the heterodimeric cofactor UFD1-NPL4 and drives p97-UFD1-NPL4-dependent proteasomal degradation of ubiquitylated substrates; while VCF1 itself has no intrinsic ubiquitin affinity, its binding to p97 indirectly stimulates UFD1-NPL4 engagement with ubiquitin conjugates (PMID:38503733). Consistent with a role in nuclear p97 function, loss of VCF1 causes slow growth and hypersensitizes cells to p97 inhibition both with and without DNA damage (PMID:37713320).

1. 2023 High

   Establishing that VCF1 is a bona fide p97 cofactor answered whether this previously uncharacterized protein physically engages the p97 segregase machinery.

   Evidence direct binding assay and reciprocal co-immunoprecipitation in cells identifying a novel alpha-helical p97-binding motif and association with p97-UFD1-NPL4 and p97-UBXN2B complexes

   PMID:37713320

   Open questions at the time

   • Did not resolve the structural basis or affinity of the binding motif
   • Functional consequence of complex association not yet defined
2. 2023 High

   Linking VCF1 to nuclear p97 import explained where and how VCF1 exerts its function on the p97 system.

   Evidence subcellular fractionation and VCF1/2 loss-of-function showing nuclear localization and reduced nuclear p97 upon depletion

   PMID:37713320

   Open questions at the time

   • Mechanism of how VCF1 drives nuclear import not defined
   • Whether import depends on the p97-binding motif untested at this stage
3. 2023 Medium

   Demonstrating growth and drug-sensitivity phenotypes established VCF1 as a functionally important regulator of nuclear p97 rather than a passive binder.

   Evidence knockout cells assayed for growth and sensitivity to chemical p97 inhibition with and without DNA damage

   PMID:37713320

   Open questions at the time

   • Single lab phenotype
   • Specific nuclear substrates or pathways affected not identified
4. 2024 High

   Quantifying the binding interaction defined the molecular determinant of VCF1-p97 engagement and distinguished it from other cofactors.

   Evidence structure-function studies, affinity measurements and mutagenesis of the alpha-helical motif recognizing the p97 N-domain

   PMID:38503733

   Open questions at the time

   • No high-resolution structure of the complex reported in the timeline
   • Functional consequence of the unusually high affinity not fully explored
5. 2024 High

   Connecting VCF1 to substrate degradation answered how its p97 binding translates into a biochemical output.

   Evidence co-immunoprecipitation and proteasomal degradation assays showing joint VCF1-UFD1-NPL4 complex formation and VCF1-dependent degradation of ubiquitylated substrates; ubiquitin-binding tests showing VCF1 lacks intrinsic ubiquitin affinity but indirectly stimulates UFD1-NPL4 binding to conjugates

   PMID:38503733

   Open questions at the time

   • Specific physiological substrates not enumerated
   • Mechanism by which p97 binding allosterically enhances UFD1-NPL4 conjugate engagement unresolved

• The identity of the nuclear substrates and pathways governed by VCF1-directed p97 activity, and the structural basis for its enhancement of UFD1-NPL4, remain open.
• No defined endogenous substrate set
• No complex structure
• Relationship between nuclear import role and degradation role not integrated